OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis
Cori Campbell, Tingyan Wang, Anna McNaughton, et al.
Journal of Viral Hepatitis (2020) Vol. 28, Iss. 3, pp. 493-507
Open Access | Times Cited: 68
Cori Campbell, Tingyan Wang, Anna McNaughton, et al.
Journal of Viral Hepatitis (2020) Vol. 28, Iss. 3, pp. 493-507
Open Access | Times Cited: 68
Showing 1-25 of 68 citing articles:
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
Hong You, Fu‐Sheng Wang, Taisheng Li, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 95
Hong You, Fu‐Sheng Wang, Taisheng Li, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 95
HBx-Induced HSPA8 Stimulates HBV Replication and Suppresses Ferroptosis to Support Liver Cancer Progression
Yufei Wang, Man Zhao, Lina Zhao, et al.
Cancer Research (2023) Vol. 83, Iss. 7, pp. 1048-1061
Open Access | Times Cited: 64
Yufei Wang, Man Zhao, Lina Zhao, et al.
Cancer Research (2023) Vol. 83, Iss. 7, pp. 1048-1061
Open Access | Times Cited: 64
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda
Emily Martyn, Sarah Eisen, Nicky Longley, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 48
Emily Martyn, Sarah Eisen, Nicky Longley, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 48
Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
Hwang Sik Shin, Baek Gyu Jun, Sang‐Wook Yi
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 773-789
Open Access | Times Cited: 51
Hwang Sik Shin, Baek Gyu Jun, Sang‐Wook Yi
Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 773-789
Open Access | Times Cited: 51
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih‐Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
Chih‐Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide
Nicole E. Rich
Surgical Oncology Clinics of North America (2023) Vol. 33, Iss. 1, pp. 1-12
Closed Access | Times Cited: 24
Nicole E. Rich
Surgical Oncology Clinics of North America (2023) Vol. 33, Iss. 1, pp. 1-12
Closed Access | Times Cited: 24
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 29
The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy?
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
Stavros P. Papadakos, Daniele Ferraro, Gabriele Carbone, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3161-3161
Open Access | Times Cited: 19
The role of NUPR1 in response to stress and cancer development
Shan Liu, Max Costa
Toxicology and Applied Pharmacology (2022) Vol. 454, pp. 116244-116244
Closed Access | Times Cited: 27
Shan Liu, Max Costa
Toxicology and Applied Pharmacology (2022) Vol. 454, pp. 116244-116244
Closed Access | Times Cited: 27
Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts
Robin Brown, Philip Goulder, Philippa C. Matthews
Wellcome Open Research (2022) Vol. 7, pp. 32-32
Open Access | Times Cited: 23
Robin Brown, Philip Goulder, Philippa C. Matthews
Wellcome Open Research (2022) Vol. 7, pp. 32-32
Open Access | Times Cited: 23
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Lesley A. Patmore, Warshan K. Katwaroe, Daniël P. C. van der Spek, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 12, pp. 3089-3096.e1
Open Access | Times Cited: 16
Lesley A. Patmore, Warshan K. Katwaroe, Daniël P. C. van der Spek, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 12, pp. 3089-3096.e1
Open Access | Times Cited: 16
Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
Mi Na Kim, Kyungdo Han, Juhwan Yoo, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 8, pp. 1448-1458
Closed Access | Times Cited: 16
Mi Na Kim, Kyungdo Han, Juhwan Yoo, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 8, pp. 1448-1458
Closed Access | Times Cited: 16
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
Rui Han, Changquan Ling, Yuqian Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Rui Han, Changquan Ling, Yuqian Wang, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
S. Panneerselvam, Cornelia M. Wilson, Prem Kumar, et al.
Cell Adhesion & Migration (2023) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
S. Panneerselvam, Cornelia M. Wilson, Prem Kumar, et al.
Cell Adhesion & Migration (2023) Vol. 17, Iss. 1, pp. 1-21
Open Access | Times Cited: 11
In vitro and in silico analyses of amino acid substitution effects at the conserved N-linked glycosylation site in hepatitis B virus surface protein on antigenicity, immunogenicity, HBV replication and secretion
Patcharin Tepjanta, Thammakorn Saethang, Kazuhito Fujiyama, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316328-e0316328
Open Access
Patcharin Tepjanta, Thammakorn Saethang, Kazuhito Fujiyama, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316328-e0316328
Open Access
Impact of Metformin on HBV Replication: No Evidence of Suppression in vitro
Christine J. Hawkins, Elizabeth Waddilove, Philippa C. Matthews, et al.
(2025)
Closed Access
Christine J. Hawkins, Elizabeth Waddilove, Philippa C. Matthews, et al.
(2025)
Closed Access
Impact of metformin on HBV replication: no evidence of suppression in vitro
Christine J. Hawkins, Elizabeth Waddilove, Philippa C. Matthews, et al.
Journal of Clinical Virology (2025), pp. 105781-105781
Open Access
Christine J. Hawkins, Elizabeth Waddilove, Philippa C. Matthews, et al.
Journal of Clinical Virology (2025), pp. 105781-105781
Open Access
Cardiometabolic Comorbidities in Patients With Chronic Hepatitis B and Impact on Incidence of Liver Complications. A Danish Nationwide Cohort Study
Sofie Jespersen, Signe Bollerup, Sten Madsbad, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1591-1604
Open Access
Sofie Jespersen, Signe Bollerup, Sten Madsbad, et al.
International Journal of General Medicine (2025) Vol. Volume 18, pp. 1591-1604
Open Access
Analysis of high-risk factors for hepatocellular carcinoma after sustained virological suppression of chronic hepatitis B
Jianna Zhang, Zhiqiang Lan, K. Zhu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Jianna Zhang, Zhiqiang Lan, K. Zhu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Impact of metabolic dysfunction-associated fatty liver disease on survival outcomes in patients undergoing radical resection for hepatitis B virus-related hepatocellular carcinoma
Ke-Gong Xiong, Tai-Shun Lin, Qing-Biao Lin, et al.
Research Square (Research Square) (2025)
Closed Access
Ke-Gong Xiong, Tai-Shun Lin, Qing-Biao Lin, et al.
Research Square (Research Square) (2025)
Closed Access
Understanding the role of Hedgehog signaling pathway and gut dysbiosis in fueling liver cancer
Naz Fatima, Hooriya Fatima, Sadia Ahmad, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Naz Fatima, Hooriya Fatima, Sadia Ahmad, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Mandy Sze‐Man Lai, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 11, pp. 2864-2875.e16
Closed Access | Times Cited: 10
Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong, Mandy Sze‐Man Lai, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 11, pp. 2864-2875.e16
Closed Access | Times Cited: 10
The interplay between chronic hepatitis B and diabetes mellitus: A narrative and concise review
Shang‐Chin Huang, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences (2023) Vol. 40, Iss. 1, pp. 6-10
Open Access | Times Cited: 10
Shang‐Chin Huang, Jia‐Horng Kao
The Kaohsiung Journal of Medical Sciences (2023) Vol. 40, Iss. 1, pp. 6-10
Open Access | Times Cited: 10
Beneficial Effects of Traditional Chinese Medicine Fuzheng Huayu on the Occurrence of Hepatocellular Carcinoma in Patients with Compensated Chronic Hepatitis B Cirrhosis Receiving Entecavir: A Multicenter Retrospective Cohort Study
Haina Fan, Shu-Juan Lei, Zhimin Zhao, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 5, pp. 505-515
Open Access | Times Cited: 3
Haina Fan, Shu-Juan Lei, Zhimin Zhao, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 12, Iss. 5, pp. 505-515
Open Access | Times Cited: 3
Liver Cancer Etiology: Old Issues and New Perspectives
Jianguo Chen, Yong-Hui Zhang, Jianhua Lu, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1452-1468
Closed Access | Times Cited: 3
Jianguo Chen, Yong-Hui Zhang, Jianhua Lu, et al.
Current Oncology Reports (2024) Vol. 26, Iss. 11, pp. 1452-1468
Closed Access | Times Cited: 3
